<DOC>
	<DOCNO>NCT01708499</DOCNO>
	<brief_summary>Enrolled subject receive one UltherapyTM treatment abdomen . Follow-up visit occur 90 180 day post-treatment . Study image obtain pre-treatment , immediately post-treatment , follow-up visit .</brief_summary>
	<brief_title>Feasibility Study : Evaluation Ulthera® System Treatment Abdominal Tissue</brief_title>
	<detailed_description>This prospective , single-center , pilot clinical trial evaluate efficacy Ulthera® System improve laxity/crepiness texture abdominal tissue . Changes baseline laxity , crepiness texture abdominal skin assess study follow-up visit . Global Aesthetic Improvement Scale score , assessment dermal thickness , patient satisfaction questionnaire also obtain .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<criteria>Male female , age 25 60 year . Subject good health . Skin laxity abdomen Understands accepts obligation undergo procedure area treat followup period . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Presence active systemic local skin disease may affect wound healing . Severe solar elastosis . Excessive subcutaneous fat abdomen . Excessive skin laxity abdomen . Significant scar area treat . Open wound lesion area treat . Inability understand protocol give inform consent . BMI equal great 30 .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy™ Treatment</keyword>
	<keyword>Ulthera , Inc .</keyword>
	<keyword>Ultrasound treatment skin tightening</keyword>
</DOC>